Davis-Hanna A et al. |
Farnesol and dodecanol effects on the Candida albicans Ras1-cAMP signalling pathway and the regulation of morphogenesis. |
2008 |
Mol. Microbiol. |
pmid:18078440
|
Haklai R et al. |
Orally administered FTS (salirasib) inhibits human pancreatic tumor growth in nude mice. |
2008 |
Cancer Chemother. Pharmacol. |
pmid:17909812
|
Zvibel I et al. |
The effect of Ras inhibition on the proliferation, apoptosis and matrix metalloproteases activity in rat hepatic stellate cells. |
2008 |
Dig. Dis. Sci. |
pmid:17934818
|
Journe F et al. |
Farnesol, a mevalonate pathway intermediate, stimulates MCF-7 breast cancer cell growth through farnesoid-X-receptor-mediated estrogen receptor activation. |
2008 |
Breast Cancer Res. Treat. |
pmid:17333335
|
Blum R et al. |
Inhibitors of chronically active ras: potential for treatment of human malignancies. |
2008 |
Recent Pat Anticancer Drug Discov |
pmid:18289122
|
Tsangarakis C et al. |
Zeolite NaY-promoted cyclization of farnesal: a short route to nanaimoal. |
2008 |
J. Org. Chem. |
pmid:18321121
|
McAlester G et al. |
Signal-mediated interactions between Pseudomonas aeruginosa and Candida albicans. |
2008 |
J. Med. Microbiol. |
pmid:18436588
|
Joo JH and Jetten AM |
NF-kappaB-dependent transcriptional activation in lung carcinoma cells by farnesol involves p65/RelA(Ser276) phosphorylation via the MEK-MSK1 signaling pathway. |
2008 |
J. Biol. Chem. |
pmid:18424438
|
Kebaara BW et al. |
Candida albicans Tup1 is involved in farnesol-mediated inhibition of filamentous-growth induction. |
2008 |
Eukaryotic Cell |
pmid:18424510
|
Rotblat B et al. |
The Ras inhibitor farnesylthiosalicylic acid (Salirasib) disrupts the spatiotemporal localization of active Ras: a potential treatment for cancer. |
2008 |
Meth. Enzymol. |
pmid:18374183
|
Lorek J et al. |
Influence of farnesol on the morphogenesis of Aspergillus niger. |
2008 |
J. Basic Microbiol. |
pmid:18383232
|
Woodard B et al. |
3D-QSAR of fungal quorum-sensing inhibiting analogs of farnesol. |
2007 Mar-Apr |
J Environ Sci Health B |
pmid:17454380
|
Bellahcène A et al. |
Zoledronate inhibits alphavbeta3 and alphavbeta5 integrin cell surface expression in endothelial cells. |
2007 Mar-Apr |
Endothelium |
pmid:17497369
|
Yue W et al. |
Mechanisms of acquired resistance to endocrine therapy in hormone-dependent breast cancer cells. |
2007 Aug-Sep |
J. Steroid Biochem. Mol. Biol. |
pmid:17616457
|
Kuroda M et al. |
Sesquiterpene farnesol inhibits recycling of the C55 lipid carrier of the murein monomer precursor contributing to increased susceptibility to beta-lactams in methicillin-resistant Staphylococcus aureus. |
2007 |
J. Antimicrob. Chemother. |
pmid:17242033
|
Navarathna DH et al. |
Exogenous farnesol interferes with the normal progression of cytokine expression during candidiasis in a mouse model. |
2007 |
Infect. Immun. |
pmid:17517874
|
Uppuluri P et al. |
Farnesol-mediated inhibition of Candida albicans yeast growth and rescue by a diacylglycerol analogue. |
2007 |
Yeast |
pmid:17583896
|
Crowell DN et al. |
Arabidopsis thaliana plants possess a specific farnesylcysteine lyase that is involved in detoxification and recycling of farnesylcysteine. |
2007 |
Plant J. |
pmid:17425716
|
Blum R et al. |
Gene expression signature of human cancer cell lines treated with the ras inhibitor salirasib (S-farnesylthiosalicylic acid). |
2007 |
Cancer Res. |
pmid:17409441
|
Vik A et al. |
Screening of terpenes and derivatives for antimycobacterial activity; identification of geranylgeraniol and geranylgeranyl acetate as potent inhibitors of Mycobacterium tuberculosis in vitro. |
2007 |
Planta Med. |
pmid:17924309
|